News & Events about Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO Get Rating) major shareholder Albert Erani sold 25,000 shares of the firms stock in a transaction dated Wednesday, April 12th. The stock was sold at an average price of $2.07, for a total transaction of $51,750.00. Following the completion of ...
Globe Newswire
2 months ago
CANTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today ...
Globe Newswire
2 months ago
Transitioning all skin substitutes to ASP-based payments has the potential to substantially reduce Medicare Part B expendituresCANTON, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture...
Globe Newswire
4 months ago
CANTON, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today ...
Globe Newswire
6 months ago
NEW YORK, Nov. 19, 2022 (GLOBE NEWSWIRE) -- Sleep Number Corporation (NASDAQ: SNBR) Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Sleep Number alleging that Defendants made false and misleading statements and failed to disclose that: (i) Sleep ...